Skip to main content
. 2019 Dec 12;12:10931–10941. doi: 10.2147/OTT.S233234

Table 1.

Clinical Characteristics of AML Patients

Characteristics Overall Cohort (n=134)
Favorable Intermediate/Normal Poor
(n=17) (n=91) (n=26)
Sex (male/female) 9/8 45/46 10/16
Age: median (range) 52 (22–77) 58 (21–88) 63.5 (18–88)
Peripheral blast, % median (range) 61 (35–90) 72 (0–98) 60 (30–99)
Bone marrow blast, % median (range) 54 (0–86) 37 (0–97) 60 (30–99)
WBC count (109/L) median (range) 22 (2–57) 20 (1–203) 11 (1–90)
Hemoglobin (g/dL) median (range) 9 (7–11) 10 (6–14) 9 (7–13)
Platelet count (109/L) median (range) 40 (9–149) 52 (8–351) 38 (9–148)
FAB classification
 M0 0 7 7
 M1 4 25 6
 M2 6 20 7
 M4 6 23 4
 M5 0 14 0
 M6 0 1 1
 M7 1 1 1
Cytogenetic abnormality
 t(8;21) 7 0 0
 inv(16) 7 0 0
 Trisomy 8 0 0 6
 Complex 0 0 16

Abbreviations: AML, acute myeloid leukemia; WBC, white blood cell; FAB, French-American-British.

HHS Vulnerability Disclosure